GMP-ready human platelet lysate for closed system bioprocessing.

Building on the success of nLiven PR, T Liven PR combines closed system compatible packaging with release against a T-Cell growth release assay. Ensure your immune cells meet optimal cell quality. T-Liven PR consistently produces cells with improved naïve and central memory phenotype.

  • Validated pathogen reduction technology using E-Beam irradiation
  • Released against a validated T-Cell growth promotion assay
  • Available in bag format
  • Large donor pool lot sizes
  • Manufactured from outdated FDA/AABB approved apheresis platelet units
  • FDA master file, PMDA Certificate of Suitability
  • Used for manufacturing in US, EU, and other clinical trials globally
  • Manufactured under a certified ISO 9001:2015 Quality Management System
  • Example CoA and IFU
  • Culture supplement to replace FBS or AB Serum
  • Biodefined composition reduces lot-to-lot variability
  • Supports a wide range of cell types including MSCs, T-Cells, NK Cells, Endothelial cells, and more
  • Promotes improved in vitro and In vivo cell quality in CAR-T applications
  • Typically used at concentrations ranging from 2% to 10%
  • Used in 2D and 3D expansion systems
  • Additional pathogen reduction applied per EU pharmacopeia